D. Breilh, C. Pobel, M.C. Saux Non Linear Pharmacokinetics of Ethanol. Analysis of Patients with NONMEM. Study I
|
D. Breilh, C. Pobel, MC. Saux Non Linear Pharmacokinetics of Ethanol. Population Model with NONMEM After an Optimal Sampling Duration. Study II
|
D. Breilh, C. Pobel, P. Rispal, MC. Saux Population of Vancomycine with Continuous Infusion Administered in Neutropenic Patients Modeling on NPEM2-NONMEM-P-PHARM
|
D. Breilh(1) , C. Pobel(1) , C. Roth(2) , M.C. Saux(1) , G.Janvier(2) Sufentanyl Pharmacokinetic-Pharmacodynamic Modelling (PK/PD) on NONMEM in 10 Patients with Coronary Surgery
|
J. Bres, D. Cupissol, J. Nouguier-Soule, Ch. Gestin-Boyer, Ü. Büttner, B. Palomba Population Distribution of Platinum Pharmacokinetic Parameters for Dosage Recommendations of CDDP and Adaptive Control during the Course of Therapy, using different Softwares.
|
B Charpiat(1) , V Breant(1) , G Tissier(1) , J M.Sab(1) , P Maire(2) , RW Jelliffe(3) How Many Patients and Blood Levels for Population Pharmacokinetic Analysis? a Study with a One Compartment Model.
|
MJ du Preez(1) , JH Botha(1) , ML McFadyen(2) and M. Adhikari(3) Effect Concentration Relationships of Theophylline in Apnoea of Prematurity
|
A.C. Falcao(1,2) , M.M. Fernandez de Gatta, A. Dominguez-Gil, J.M. Lanao Sampling Strategies for Population Analysis: a Theoretical Study to Support Practical Results Obtained with Caffeine in Premature Neonates
|
N.S. Houwing, F. Rombout Population Pharmacokinetics: Effect of Sampling Scheme on Parameter Estimation.
|
Graham Lockwood, Gary Maier The use of Population Pharmacokinetic Approaches to Aid in the Assessment of Bioequivalence for a Highly Variable Drug
|
M. Looby, U. Wünscher, M. Weiss NONMEM in Destructive Sampling Experiments; Experiences with the Toxicokinetics of Dibromchloromethane
|
M.T. Mateu-Garcia, J.J. Perez-Ruixo, V.G. Casabo-Alos, N.V. Jimenez-Torres Apache II as Predictor of Gentamicin Pharmacokinetic Parameters in Critical Ill Patients
|
F. Mesnil(1) , F. Mentre(1) , C. Dubrue(2) , A. Mallet(1) Population Pharmacokinetics Analysis of Mizolastine: Estimation with NPML and Validation
|
P. Milligan(1) , M. Karlsson(2) , D. Nichols(1) High Variability Compounds - High Risk for Developers?
|
JPR Monteleone and NHG Holford Modeling Interoccasion Variability in Toxicokinetics and Toxicodynamics
|
L.S. Murray(1) , D.I. Jodrell(2) . J.G. Morrison(2) , A.W. Kelman(1) , D.J. Kerr(2) , B.Whiting(1) & S.B. Kaye(2) A Population Approach to Predicting Post-Treatment Levels of Epirubicin in Patients with Advanced Breast Cancer
|
Helene Peyriere(1) , Janine Bres(1) , Dominique Hillaire-Buys(2) Performance Evaluation of Three Softwares for Bayesian Predictions of Teicoplanin Pharmacokinetic Parameters: APIS MICROPHARM, PKS Abbott
|
S. Rietbrock, S. Harder, H. Baas Influence of Apomorphine on the PK/PD-Relationship of Levodopa: Two-Step versus NONMEM Analysis
|
M. Sandström(1) , A. Freijs(1) , R. Larsson(2) , P. Nygren(3) , J. Bergh(3) , M-L. Fjällskog(3) , M.O. Karlsson(1) , Lack of Relationship between Systemic Exposure for the Component Drugs of the FEC Regimen in Breast Cancer Patients
|
D. Santos Buelga, M.F. Delgado Iribarnegaray, M.J. Garca, M.J. Otero, A. Falcao, A. Dominguez-Gil Carbamazepine Population Pharmacokinetics in Children
|
Rik Schoemaker and Adam Cohen Estimation of Kinetic/Dynamic Curves With Insufficient Information for Each Individual Using Non-Linear Mixed Effect Modelling
|
M. Tod(1) and Jean-Marie Rocchisani(2) An Algorithm for the Estimation of Optimal Sampling Times in Pharmacokinetics by the ED, EID and API Criteria
|
M. Tod*(1) , C. Padoin(1) , C. Minozzi(2) , J. Cougnard(2) , O. Petitjean(1) A Population Pharmacokinetic Study of Isepamicin in ICU Patients
|
B. Tranchand, S. Urien, C. J. Ardiet Population Pharmacokinetics of Intravenous Melphalan: NONMEM and MP2 Analysis
|
Saik Urien (I.N.S.E.R.M.) MP2 (MicroPharm Population): A Windows Application for Population Pharmacokinetics
|
Janet R Wade(1) , Britt-Marie Emanuelsson(2) , Lars L Gustafsson(3) , A Population Approach Enables the Characterisation of Saturable Protein Binding for Ropivacaine
|
J Wakefield, G Strehlau Software product POPKAN; Population pharmacokinetic modelling and analysis
|
W. Weber*, L. Harnisch, M. Zimmer, C. Rokitta, P. Mendes New Evidence for a Triexponential Disposition of Cefotaxime
|